Related Experiment Video

Updated: Nov 21, 2025

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.5K

Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies

Jie Zhang1, Hilary Grosso Jasutkar1, M Maral Mouradian1

  • 1Robert Wood Johnson Medical School Institute for Neurological Therapeutics, and Department of Neurology, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.

Neural Regeneration Research
|January 12, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models08:44

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models

Published on: November 11, 2014

8.4K
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.0K

Related Concept Videos